Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferris

Showing results (431-440 of 460) with videos related to

Pageof 46
Sort By:
Clinical and Vaccine Immunology : CVI|December 14, 2011
Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years oldRichard J Hillman, Anna R Giuliano, Joel M Palefsky, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare EfficiencyJason H Wasfy, Kevin F Kennedy, Frederick A Masoudi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearanceRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
International Journal of Cancer|May 28, 2010
The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trialsMark H Stoler, Michelle D Vichnin, Alex Ferenczy, et al.
Lancet (London, England)|November 16, 2004
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialDiane M Harper, Eduardo L Franco, Cosette Wheeler, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Clinical and Vaccine Immunology : CVI|April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccinesSuzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.
Scientific Reports|October 10, 2019
Volcanic glass properties from 1459 C.E. volcanic event in South Pole ice core dismiss Kuwae caldera as a potential sourceLaura H Hartman, Andrei V Kurbatov, Dominic A Winski, et al.
The Journal of Infectious Diseases|December 15, 2010
External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continentsEftyhia Vardas, Anna R Giuliano, Stephen Goldstone, et al.
The Journal of Infectious Diseases|December 15, 2010
Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with menStephen Goldstone, Joel M Palefsky, Anna R Giuliano, et al.
Pageof 46

Showing results (431-440 of 460) with videos related to

Sort By:
Pageof 46
Clinical and Vaccine Immunology : CVI|December 14, 2011
Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years oldRichard J Hillman, Anna R Giuliano, Joel M Palefsky, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare EfficiencyJason H Wasfy, Kevin F Kennedy, Frederick A Masoudi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearanceRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
International Journal of Cancer|May 28, 2010
The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trialsMark H Stoler, Michelle D Vichnin, Alex Ferenczy, et al.
Lancet (London, England)|November 16, 2004
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialDiane M Harper, Eduardo L Franco, Cosette Wheeler, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Clinical and Vaccine Immunology : CVI|April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccinesSuzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.
Scientific Reports|October 10, 2019
Volcanic glass properties from 1459 C.E. volcanic event in South Pole ice core dismiss Kuwae caldera as a potential sourceLaura H Hartman, Andrei V Kurbatov, Dominic A Winski, et al.
The Journal of Infectious Diseases|December 15, 2010
External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continentsEftyhia Vardas, Anna R Giuliano, Stephen Goldstone, et al.
The Journal of Infectious Diseases|December 15, 2010
Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with menStephen Goldstone, Joel M Palefsky, Anna R Giuliano, et al.
Pageof 46